By Kim Richters
Bayer AG (BAYN.XE) said Wednesday that it will invest around 100 million euros ($109.5 million) in its sites in the German capital Berlin.
The pharmaceutical and chemical giant said that it will invest in innovative technologies and build a sterile production site at its sites in Berlin.
The investment will be used to "expand capacities for technological development, clinical care and market introduction of new products," it said.
Write to Kim Richters at firstname.lastname@example.org